Influenza Hemagglutinin (HA) Peptide: Precision Tag for Protein Purification and Detection

Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic, nine-amino acid tag derived from the influenza virus hemagglutinin protein's epitope region, optimally designed for protein tagging and detection (A6004 product data). This peptide exhibits high solubility (≥100.4 mg/mL in ethanol; ≥55.1 mg/mL in DMSO; ≥46.2 mg/mL in water) and purity (>98%, confirmed by HPLC and MS), allowing for reliable integration into diverse biochemical workflows (ApexBio, 2024). The HA peptide functions as a competitive binder in immunoprecipitation assays, facilitating the elution of HA-tagged fusion proteins from anti-HA antibody matrices (Wei et al., 2021). It supports reproducible protein-protein interaction studies and serves as a gold standard for epitope tagging in translational research (related article). Proper storage (desiccated at -20°C) is crucial for stability, with long-term solution storage not recommended (ApexBio, 2024).

Biological Rationale

The Influenza Hemagglutinin (HA) Peptide is derived from the N-terminal region of the hemagglutinin protein of human influenza virus (residues 98–106, sequence: YPYDVPDYA) (A6004). The HA tag's small size minimizes disruption to the structure and function of fused proteins, preserving biological activity in most contexts (see contrast: this article details storage parameters and solubility data). The peptide's epitope is specifically recognized by high-affinity monoclonal anti-HA antibodies, enabling selective detection and purification of HA-tagged proteins in mammalian, yeast, and bacterial systems. The HA tag was originally popularized for its use in immunoprecipitation, western blotting, and protein localization studies (compare: this article focuses on exosome workflows; this article provides quantitative benchmarks).

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The HA peptide tag functions by providing a unique, exogenous epitope on a fusion protein. Monoclonal anti-HA antibodies bind this epitope with high specificity and affinity, enabling the capture of HA-tagged proteins from complex mixtures (Wei et al., 2021). During immunoprecipitation, the synthetic HA peptide (A6004) is added in excess to competitively elute the HA fusion protein from the antibody matrix. This competitive displacement is highly efficient due to the peptide's strong antibody affinity and chemical stability. The peptide's high solubility ensures rapid distribution in aqueous buffers, facilitating quick and complete elution (A6004).

Evidence & Benchmarks

• HA peptide (YPYDVPDYA) enables efficient competitive elution of HA-tagged proteins in immunoprecipitation assays, reducing background and increasing yield compared to co-elution or harsh buffer conditions (Wei et al., 2021).
• Solubility benchmarks: ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, ≥46.2 mg/mL in water at 25°C, facilitating compatibility with diverse assay buffers (A6004).
• High purity (>98%) confirmed by HPLC and mass spectrometry provides reproducibility and minimizes off-target effects in protein interaction studies (A6004).
• HA tag fusion does not disrupt most protein functions, as evidenced by widespread use in exosome, signaling, and cancer biology workflows (see: this article explores new cancer signaling paradigms enabled by the HA tag).
• Competitive elution with HA peptide preserves the structural integrity of target proteins, outperforming acidic or denaturing elution methods in preserving protein complexes (Smith 2023, Wei et al., 2021).

Applications, Limits & Misconceptions

The Influenza Hemagglutinin (HA) Peptide is commonly used in:

• Immunoprecipitation (IP) and co-immunoprecipitation (Co-IP) assays for protein-protein interaction mapping.
• Affinity purification of HA-tagged proteins using anti-HA antibody-conjugated beads or columns.
• Western blot detection and immunofluorescence localization of fusion proteins.
• Competitive displacement of HA-fusion proteins during elution, enabling gentle, non-denaturing recovery.

Limits & Misconceptions:

Common Pitfalls or Misconceptions

1. The HA peptide does not function as a universal purification tag for all proteins; steric hindrance or local folding may mask the epitope.
2. Long-term storage of HA peptide in solution is not recommended; desiccated storage at -20°C is necessary to preserve integrity (A6004).
3. Excessive HA peptide in elution buffers can interfere with downstream antibody-based assays if not removed by dialysis or buffer exchange.
4. The HA tag is not suitable for in vivo therapeutic use; it is a research reagent only.
5. Epitope masking by N- or C-terminal fusion context or post-translational modifications may reduce antibody binding.

Workflow Integration & Parameters

The Influenza Hemagglutinin (HA) Peptide (A6004) is supplied as a lyophilized powder. For use, reconstitute in DMSO, ethanol, or water to the required concentration (e.g., 1–10 mg/mL). For immunoprecipitation elution, add at a final concentration of 1–2 mg/mL to the antibody-bead complex and incubate at 4°C for 30–60 minutes. Removal of the peptide post-elution is recommended for applications sensitive to free epitope. Store unused peptide desiccated at -20°C; avoid repeated freeze-thaw cycles. Do not store reconstituted peptide long-term. The peptide's high solubility and purity facilitate its use in high-throughput workflows and multi-omics applications (see: this article focuses on compatibility with diverse molecular workflows; this article expands on proteinabeads integration).

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide remains a gold-standard molecular tag for protein detection, purification, and interaction studies, underpinned by strong evidence for specificity, solubility, and reproducibility (Wei et al., 2021). Its performance is validated across diverse research domains, from exosome biogenesis to cancer signaling. Future advances may further optimize tag-antibody pairs and expand the HA tag’s utility for quantitative proteomics and single-cell workflows. For detailed specifications and ordering information, visit the Influenza Hemagglutinin (HA) Peptide product page.